PUBLISHER: Grand View Research | PRODUCT CODE: 1363218
PUBLISHER: Grand View Research | PRODUCT CODE: 1363218
The global traumatic brain injuries assessment and management devices market size is anticipated to reach USD 5.53 billion by 2030, registering a CAGR of 7.6% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Increasing cases of car accidents and injuries caused due to sports, as well as rising patient preference for minimally invasive procedures, are driving the market growth. Falls are one of the leading causes of hospitalization in traumatic brain injuries (TBI) patients followed by motor vehicle accidents. According to the CDC, presently 3.5 million people are living with permanent TBI-related disability in the U.S.Thus, the increasing incidence of TBIs due to mounting cases of road accidents, and injuries are expected to fuel the product demand.
The COVID-19 outbreak in the year 2020 is expected to have a short-term and moderate impact on the market. Patients suffering from COVID-19 have subsequently shown neurologic symptoms that are expected to create a favorable environment for market growth in the near future. As per the research study published in the NCBI report 2020, certain patients hospitalized for coronavirus infection showed clinical & neurochemical signs of brain injury. This is expected to boost the product demand during the forecast period. The incorporation of the latest technologies and the introduction of new products by market players are also to drive the market during the forecast period. For instance, NanoDx System, launched by BioDirection Company, is a rapid Point-of-Care (POC) test that precisely confirms concussion/TBI in less than two minutes.